{"article_title": "Wearables Final Four: Wearable defibrillator edges out smart bra for breast cancer detection", "article_keywords": ["heart", "vest", "wearables", "cancer", "warnings", "things", "reduce", "patients", "wearable", "detection", "bra", "edges", "breast", "device", "defibrillator", "final", "smart", "zoll"], "article_url": "http://medcitynews.com/2014/04/wearables-final-four-wearable-defibrillator-beats-smart-bra-breast-cancer-detection/", "article_text": "Heart disease is one of the trio of chronic diseases that the Affordable Care Act aims to improve. Although a portable defibrillator won\u2019t reduce readmissions for heart disease patients and those who have had heart surgery, it can save lives.\n\nI am picking ZOLL Medical\u2019s Life Vest over First Warning\u2019s smart bra for a few reasons. It adds a safety net for vulnerable patients when they\u2019re discharged from the hospital. The patients who would be prescribed this device tend to be waiting for a heart transplant, recently suffered a myocardial infarction or recently had a procedure such as cardiac bypass surgery or coronary angioplasty.\n\nAlthough the device was cleared by the FDA several years ago, the company is still seeking indications that would make it more routinely prescribed. It also speaks to wider need for accessible defibrillators to respond to sudden heart attacks.\n\nReaders saw things differently. The smart bra captured 61 percent of the vote and the Life Vest only received 39 percent.\n\nAdvertisement\n\nOne of the things that I like about First Warning\u2019s smart bra technology is that it can passively alert people to possible problems and poses some interesting ways to reduce breast cancer. It\u2019s also designed to reduce the number of false positives that can lead to unnecessary biopsies. Its CEO sees it fulfilling a need, particularly in women under 40 who have dense breast tissue. It has planned a clinical validation trial in the second half of the year. But ZOLL\u2019s device has the potential to save more people.\n\nWinner: ZOLL Medical", "article_metadata": {"description": "Heart disease is one of the trio of chronic diseases that the Affordable Care Act aims to improve. Although a portable defibrillator won\u2019t reduce readmissions for heart disease patients and those who have had heart surgery, it can save lives. I am picking ZOLL Medical\u2019s Life Vest over First Warning\u2019s smart bra for a few reasons.\u00a0 It adds a safety net for vulnerable patients when they\u2019re discharged from the hospital. The patients who would be prescribed this device tend to be waiting for a heart transplant, recently suffered a myocardial infarction or recently had a procedure such as cardiac bypass surgery or coronary angioplasty. Although the device was cleared by the FDA several years ago, the company is still seeking indications that would make it more routinely prescribed. It also speaks to wider need for accessible defibrillators to respond to sudden heart attacks. Readers saw things differently. The smart bra captured 61 percent of the vote and the Life Vest only received 39 percent. One of the things that I like about First Warning\u2019s smart bra technology is that it can passively alert people to possible problems and poses some interesting ways to reduce breast cancer. It\u2019s also designed to reduce the number of false positives that can lead to unnecessary biopsies. Its CEO sees it fulfilling a need, particularly in women under 40 who have dense breast tissue. It has planned a clinical validation trial in the second half of the year. But ZOLL\u2019s device has the potential to save more people. Winner: ZOLL Medical", "generator": "WordPress 4.5.2", "og": {"site_name": "MedCity News", "description": "Heart disease is one of the trio of chronic diseases that the Affordable Care Act aims to improve. Although a portable defibrillator won\u2019t reduce readmissions for heart disease patients and those who have had heart surgery, it can save lives. I am picking ZOLL Medical\u2019s Life Vest over First Warning\u2019s smart bra for a few reasons.\u00a0 It adds a safety net for vulnerable patients when they\u2019re discharged from the hospital. The patients who would be prescribed this device tend to be waiting for a heart transplant, recently suffered a myocardial infarction or recently had a procedure such as cardiac bypass surgery or coronary angioplasty. Although the device was cleared by the FDA several years ago, the company is still seeking indications that would make it more routinely prescribed. It also speaks to wider need for accessible defibrillators to respond to sudden heart attacks. Readers saw things differently. The smart bra captured 61 percent of the vote and the Life Vest only received 39 percent. One of the things that I like about First Warning\u2019s smart bra technology is that it can passively alert people to possible problems and poses some interesting ways to reduce breast cancer. It\u2019s also designed to reduce the number of false positives that can lead to unnecessary biopsies. Its CEO sees it fulfilling a need, particularly in women under 40 who have dense breast tissue. It has planned a clinical validation trial in the second half of the year. But ZOLL\u2019s device has the potential to save more people. Winner: ZOLL Medical", "title": "Wearables Final Four: Wearable defibrillator edges out smart bra for breast cancer detection", "locale": "en_US", "image": "http://medcitynews.com/wp-content/uploads/bigstock-Business-Race-319699.jpg", "updated_time": "2014-04-10T10:16:39-04:00", "url": "http://medcitynews.com/2014/04/wearables-final-four-wearable-defibrillator-beats-smart-bra-breast-cancer-detection/", "type": "article"}, "twitter": {"image": "http://medcitynews.com/wp-content/uploads/bigstock-Business-Race-319699.jpg", "description": "Heart disease is one of the trio of chronic diseases that the Affordable Care Act aims to improve. Although a portable defibrillator won\u2019t reduce readmissions for heart disease patients and those who have had heart surgery, it can save lives. I am picking ZOLL Medical\u2019s Life Vest over First Warning\u2019s smart bra for a few reasons.\u00a0 It adds a safety net for vulnerable patients when they\u2019re discharged from the hospital. The patients who would be prescribed this device tend to be waiting for a heart transplant, recently suffered a myocardial infarction or recently had a procedure such as cardiac bypass surgery or coronary angioplasty. Although the device was cleared by the FDA several years ago, the company is still seeking indications that would make it more routinely prescribed. It also speaks to wider need for accessible defibrillators to respond to sudden heart attacks. Readers saw things differently. The smart bra captured 61 percent of the vote and the Life Vest only received 39 percent. One of the things that I like about First Warning\u2019s smart bra technology is that it can passively alert people to possible problems and poses some interesting ways to reduce breast cancer. It\u2019s also designed to reduce the number of false positives that can lead to unnecessary biopsies. Its CEO sees it fulfilling a need, particularly in women under 40 who have dense breast tissue. It has planned a clinical validation trial in the second half of the year. But ZOLL\u2019s device has the potential to save more people. Winner: ZOLL Medical", "card": "summary", "title": "Wearables Final Four: Wearable defibrillator edges out smart bra for breast cancer detection - MedCity News"}, "robots": "noodp", "fb": {"app_id": 148725768475669}, "google-site-verification": "xudQg7nxVR9ifmMTY4Tf-0wVtX9b6rWLQd0utCweGOc", "keywords": "weight loss, obesity, overweight,diabetes,massachusetts,medical devices,obesity,startups,healthcare innovation, medcity news,medcity news,san francisco, startups, life sciences,accelerator,rock health,startup advice,startup funding,patient monitoring system, motion sensors ,dc,healthcare it,washington,foodborne pathogens, diagnostics company, diagnostic platforms,minimally invasive surgery, laser surgery,cambridge,dealflow,hospitals,wellpoint, healthways, health and wellness, employee wellness programs,investing,wellness,medtronic, shanghai innovation center, china, r&d,china,mdt,minneapolis,minnesota,publics,twin cities,ulcerative colitis, abbott labs, humira,abbott labs,doctors,pharmaceuticals,skin disorders, pharmaceuticals, md anderson cancer center,cancer,texas,renal denervation, st. jude medical,st. jude medical,stj,emr, ehr, electronic health records, electronic medical records, certified emr,certified emr,ehr,electronic health records,electronic medical records,advanced cellular technology,amyotrophic lateral sclerosis,embryonic stem cells,geron corporation,lou gehrig\\'s disease,macular degeneration,regenerative medicine,spinal cord damage,value-based healthcare system, obamacare, fee-for-service model,california,cleveland,health insurance,insurance,ohio,pennsylvania,politics,cancer treatment options library, aetna, aet, healthcare it,aet,aetna,health it,phi,philadelphia,breast cancer awareness, First Warning systems, heart disease treatment, Wearables Final Four, Zoll Medical, , MedCity News", "article": {"section": "Daily", "tag": "Zoll Medical", "published_time": "2014-04-10T06:35:22-04:00", "modified_time": "2014-04-10T10:16:39-04:00"}, "viewport": "width=device-width,initial-scale=1.0,width=device-width,user-scalable=no,minimum-scale=1.0,maximum-scale=1.0"}, "article_summary": "I am picking ZOLL Medical\u2019s Life Vest over First Warning\u2019s smart bra for a few reasons.\nThe smart bra captured 61 percent of the vote and the Life Vest only received 39 percent.\nAdvertisementOne of the things that I like about First Warning\u2019s smart bra technology is that it can passively alert people to possible problems and poses some interesting ways to reduce breast cancer.\nAlthough a portable defibrillator won\u2019t reduce readmissions for heart disease patients and those who have had heart surgery, it can save lives.\nHeart disease is one of the trio of chronic diseases that the Affordable Care Act aims to improve."}